Rutkowski, P.; Pauwels, P.; Kerger, J.; Jacobs, B.; Maertens, G.; Gadeyne, V.; Thielemans, A.; de Backer, K.; Neyns, B.
Characterization and Clinical Utility of BRAFV600 Mutation Detection Using Cell-Free DNA in Patients with Advanced Melanoma. Cancers 2021, 13, 3591.
https://doi.org/10.3390/cancers13143591
AMA Style
Rutkowski P, Pauwels P, Kerger J, Jacobs B, Maertens G, Gadeyne V, Thielemans A, de Backer K, Neyns B.
Characterization and Clinical Utility of BRAFV600 Mutation Detection Using Cell-Free DNA in Patients with Advanced Melanoma. Cancers. 2021; 13(14):3591.
https://doi.org/10.3390/cancers13143591
Chicago/Turabian Style
Rutkowski, Piotr, Patrick Pauwels, Joseph Kerger, Bart Jacobs, Geert Maertens, Valerie Gadeyne, Anne Thielemans, Katrien de Backer, and Bart Neyns.
2021. "Characterization and Clinical Utility of BRAFV600 Mutation Detection Using Cell-Free DNA in Patients with Advanced Melanoma" Cancers 13, no. 14: 3591.
https://doi.org/10.3390/cancers13143591
APA Style
Rutkowski, P., Pauwels, P., Kerger, J., Jacobs, B., Maertens, G., Gadeyne, V., Thielemans, A., de Backer, K., & Neyns, B.
(2021). Characterization and Clinical Utility of BRAFV600 Mutation Detection Using Cell-Free DNA in Patients with Advanced Melanoma. Cancers, 13(14), 3591.
https://doi.org/10.3390/cancers13143591